Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  23 results for ""Eplerenone""

Your Filters

Publisher : biomed central Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Unilateral adrenalectomy for a drug-resistant bilateral primary aldosteronism with heart failure: pathophysiology and surgical indication.

  • Authors : Hoshi S; Departments of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan. .; Onagi A

Subjects: Heart Failure* ; Hyperaldosteronism*/Hyperaldosteronism*/Hyperaldosteronism*/complications ; Hypertension*/Hypertension*/Hypertension*/etiology

  • Source: BMC endocrine disorders [BMC Endocr Disord] 2023 Nov 07; Vol. 23 (1), pp. 243. Date of Electronic Publication: 2023 Nov 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Agoraphobia and panic attacks complicated by primary aldosteronism improved by treatment with eplerenone: a case report.

  • Authors : Kijima R; Department of Psychiatry, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, 8078555, Kitakyushu, Fukuoka, Japan. .; Tesen H

Subjects: Panic Disorder*/Panic Disorder*/Panic Disorder*/complications ; Panic Disorder*/Panic Disorder*/Panic Disorder*/drug therapy ; Hypertension*

  • Source: BMC psychiatry [BMC Psychiatry] 2023 Oct 27; Vol. 23 (1), pp. 787. Date of Electronic Publication: 2023 Oct 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial.

  • Authors : Girerd S; Transplant Unit, Nephrology Department, Nancy University Hospital, Lorraine University, Vandoeuvre-lès-Nancy, France. .; INSERM U1116, Clinical Investigation Center, Lorraine University, Vandoeuvre-lès-Nancy, France. .

Subjects: Kidney Transplantation* ; Randomized Controlled Trials as Topic*; Eplerenone/Eplerenone/Eplerenone/*therapeutic use

  • Source: Trials [Trials] 2018 Oct 30; Vol. 19 (1), pp. 595. Date of Electronic Publication: 2018 Oct 30.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial.

  • Authors : Raman SV; Ohio State University, 473 W. 12th Ave, Suite 200, Columbus, OH, 43210, USA. .; Hor KN

Subjects: Cardiomyopathies/Cardiomyopathies/Cardiomyopathies/*drug therapy ; Cardiomyopathies/Cardiomyopathies/Cardiomyopathies/*etiology ; Mineralocorticoid Receptor Antagonists/Mineralocorticoid Receptor Antagonists/Mineralocorticoid Receptor Antagonists/*therapeutic use

  • Source: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2017 Feb 20; Vol. 12 (1), pp. 39. Date of Electronic Publication: 2017 Feb 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101266602 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial

Subjects: Mineralocorticoid receptor antagonist High-dose eplerenone Global longitudinal strain Systolic and diastolic function; Mineralocorticoid receptor antagonist; High-dose eplerenone

  • Source: ISSN: 1471-2261 ; BMC Cardiovascular Disorders ; https://hal.univ-lorraine.fr/hal-04055755 ; BMC Cardiovascular Disorders, 2023, 23 (1), pp.175. ⟨10.1186/s12872-023-03183-1⟩.

Record details

Read More Add to Saved list
×
Academic Journal

Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects.

  • Authors : Ménard J; Université Paris Descartes, Faculté de Médecine and INSERM/AP-HP Clinical Investigation Center, Georges Pompidou Hospital, Paris, France. .; Rigel DF

Subjects: Disease Models, Animal* ; Translational Research, Biomedical*; Angiotensinogen/Angiotensinogen/Angiotensinogen/*physiology

  • Source: Journal of translational medicine [J Transl Med] 2014 Dec 10; Vol. 12, pp. 340. Date of Electronic Publication: 2014 Dec 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone/Eplerenone): incidence, morphology, and ultrastructural findings.

Subjects: Adrenal Glands/Adrenal Glands/Adrenal Glands/*pathology ; Hyperaldosteronism/Hyperaldosteronism/Hyperaldosteronism/*pathology ; Hypertension/Hypertension/Hypertension/*drug therapy

  • Source: Diagnostic pathology [Diagn Pathol] 2014 Aug 09; Vol. 9, pp. 147. Date of Electronic Publication: 2014 Aug 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101251558 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes.

Subjects: Apoptosis/Apoptosis/Apoptosis/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetic Cardiomyopathies/Diabetic Cardiomyopathies/Diabetic Cardiomyopathies/*prevention & control

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2013 Nov 21; Vol. 12, pp. 172. Date of Electronic Publication: 2013 Nov 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Rationale and design of a randomized trial on the impact of aldosterone antagonism on cardiac structure and function in diabetic cardiomyopathy.

  • Authors : Leung M; Department of Cardiology, Liverpool Hospital, Locked Bag 7103, Liverpool BC, NSW 1871, Australia. .; Wong VW

Subjects: Research Design*; Cardiovascular Agents/Cardiovascular Agents/Cardiovascular Agents/*therapeutic use ; Diabetic Cardiomyopathies/Diabetic Cardiomyopathies/Diabetic Cardiomyopathies/*drug therapy

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2013 Oct 01; Vol. 12, pp. 139. Date of Electronic Publication: 2013 Oct 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism.

  • Authors : Eudy RJ; Department of Cardiovascular, Metabolic, and Endocrine Diseases, Pfizer, Eastern Point Road, Groton, CT, USA.; Sahasrabudhe V

Subjects: Mineralocorticoid Receptor Antagonists* ; Translational Research, Biomedical*; Aldosterone/Aldosterone/Aldosterone/*blood

  • Source: Journal of translational medicine [J Transl Med] 2011 Oct 21; Vol. 9, pp. 180. Date of Electronic Publication: 2011 Oct 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  23 results for ""Eplerenone""